L-BASE CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for L-BASE CO., LTD..The latest application filed is for "novel oligopeptide, and pharmaceutical composition for preventing or treating cancer, comprising the same as an active ingredient".

Company Profile

8.8.10

L-BASE CO., LTD. - Seoul KR
L-BASE CO., LTD - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Oligopeptide, And Pharmaceutical Composition For Preventing Or Treating Cancer, Comprising The Same As An Active Ingredient App 20220204560 - Jeon; Do Yong ; et al.	2022-06-30
Pharmaceutical Composition For Preventing Or Treating Cancer, Containing Oligopeptide As Active Ingredient App 20220023378 - JEON; Do Yong	2022-01-27
Composition For Autophagy Inhibiting In Cell, And Pharmaceutical Composition For Preventing Or Treating Neoplastic Disease Or Inhibiting Anti-cancer Agents Resistance Containing The Same App 20200361989 - JEON; Do Yong ; et al.	2020-11-19
Composition for autophagy inhibiting in cell, and pharmaceutical composition for preventing or treating tumor disease, or inhibiting anti-cancer agents resistance containing the same Grant 10,766,926 - Jeon , et al. Sep	2020-09-08
Compositions for overcoming anti-cancer drug-resistance or compositions for anti-cancer activity employing CAGE-derived peptides Grant 10,716,826 - Jeoung , et al.	2020-07-21
Composition For Autophagy Inhibiting In Cell, And Pharmaceutical Composition For Preventing Or Treating Tumor Disease, Or Inhibi App 20200087344 - JEON; Do Yong ; et al.	2020-03-19
Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells Grant 10,239,924 - Jeoung , et al.	2019-03-26
Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells Grant 10,233,221 - Jeoung , et al.	2019-03-19
Compositions for Overcoming Anti-Cancer Drug-Resistance or Compositions for Anti-Cancer Activity Employing Cage-Derived Peptides App 20180085422 - Jeoung; Dooil ; et al.	2018-03-29
Peptide Having Eight Amino Acid Sequences Derived From Cage And Retaining Anticancer Activity And Activity To Promote Anticancer Drug Sensitivity Of Anticancer Drug-resistant Cancer Cells App 20180079792 - Jeoung; Doo II ; et al.	2018-03-22
Peptide Having Eight Amino Acid Sequences Derived From Cage And Retaining Anticancer Activity And Activity To Promote Anticancer Drug Sensitivity Of Anticancer Drug-resistant Cancer Cells App 20180057532 - Jeoung; Doo II ; et al.	2018-03-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.